WO US · App #1592276 · Reg #1592276
Owned by
Revance Therapeutics, Inc.Application date
2021-02-19
Registration date
2021-02-19
Published date
2021-05-20
First use date
—
Renewal date
—
Expiry date
2031-02-19
Kind of mark
Individual
Mark feature
Figurative
NICE Classes
5Pharmaceuticals
Current owners
Representatives
- Kilpatrick Townsend & Stockton LLP
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
0
Security: 0
Renewals
0
Prosecution events
0
History Timeline
9 events- 2022-12-14RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 16613863 · Pub# 2023/4 Gaz · @ CA
- 2022-09-19RecordOPN - Notification of possible opposition after 18 months— Pub# 2022/40 Gaz · @ CA
- 2022-03-29RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15710054 · Pub# 2022/13 Gaz · @ BR
- 2022-03-21RecordOPN - Notification of possible opposition after 18 months— Pub# 2022/12 Gaz · @ CA
- 2021-11-30RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 15289487 · Pub# 2021/48 Gaz · @ NZ
- 2021-08-27RecordISN - Intermediate status regarding protection— Proc# 14968515 · Pub# 2021/35 Gaz · @ NZ
- 2021-08-04RecordGP18N - Grant of Protection under Rule 18bis(1)— Proc# 14896034 · Pub# 2021/31 Gaz · @ AU
- 2021-05-28RecordISN - Intermediate status regarding protection— Proc# 14680051 · Pub# 2021/21 Gaz · @ AU
- 2021-02-19RecordENN - New International Registration— Pub# 2021/18 Gaz · @ US